Substituted tetracycline compounds
The present invention pertains, at least in part, to novel substituted tetracycline compounds. These tetracycline compounds can be used to treat numerous tetracycline 5 compound-responsive states, such as bacterial infections and neoplasms, as well as other known applications for tetracycline compou...
Gespeichert in:
Hauptverfasser: | , , , , , , , , , , , , , , , , |
---|---|
Format: | Patent |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | |
container_start_page | |
container_title | |
container_volume | |
creator | ASSEFA, HAREGEWEIN BOWSER, TODD BERNIAC, JOEL NIHLAWI, MOHAMMED MECHICHE, RACHID OHEMENG, KWASI KIM, OAK BHATIA, BEENA ABATO, PAUL HONEYMAN, LAURA GRIER, MARK HOHOS, AARON CHEN, JACKSON SIZENSKY, EMMANUELLE AMOO, VICTOR NELSON, MARK L MAIL, MOHAMED Y |
description | The present invention pertains, at least in part, to novel substituted tetracycline compounds. These tetracycline compounds can be used to treat numerous tetracycline 5 compound-responsive states, such as bacterial infections and neoplasms, as well as other known applications for tetracycline compounds such as blocking tetracycline efflux and modulation of gene expression. |
format | Patent |
fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_AU2012200575A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>AU2012200575A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_AU2012200575A13</originalsourceid><addsrcrecordid>eNrjZFAKLk0qLsksKS1JTVEoSS0pSkyuTM7JzEtVSM7PLcgvzUsp5mFgTUvMKU7lhdLcDMpuriHOHrqpBfnxqcUFicmpeakl8Y6hRgaGRkYGBqbmpo6GxsSpAgCYfieI</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Substituted tetracycline compounds</title><source>esp@cenet</source><creator>ASSEFA, HAREGEWEIN ; BOWSER, TODD ; BERNIAC, JOEL ; NIHLAWI, MOHAMMED ; MECHICHE, RACHID ; OHEMENG, KWASI ; KIM, OAK ; BHATIA, BEENA ; ABATO, PAUL ; HONEYMAN, LAURA ; GRIER, MARK ; HOHOS, AARON ; CHEN, JACKSON ; SIZENSKY, EMMANUELLE ; AMOO, VICTOR ; NELSON, MARK L ; MAIL, MOHAMED Y</creator><creatorcontrib>ASSEFA, HAREGEWEIN ; BOWSER, TODD ; BERNIAC, JOEL ; NIHLAWI, MOHAMMED ; MECHICHE, RACHID ; OHEMENG, KWASI ; KIM, OAK ; BHATIA, BEENA ; ABATO, PAUL ; HONEYMAN, LAURA ; GRIER, MARK ; HOHOS, AARON ; CHEN, JACKSON ; SIZENSKY, EMMANUELLE ; AMOO, VICTOR ; NELSON, MARK L ; MAIL, MOHAMED Y</creatorcontrib><description>The present invention pertains, at least in part, to novel substituted tetracycline compounds. These tetracycline compounds can be used to treat numerous tetracycline 5 compound-responsive states, such as bacterial infections and neoplasms, as well as other known applications for tetracycline compounds such as blocking tetracycline efflux and modulation of gene expression.</description><language>eng</language><subject>ACYCLIC OR CARBOCYCLIC COMPOUNDS ; CHEMISTRY ; METALLURGY ; ORGANIC CHEMISTRY</subject><creationdate>2012</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20120223&DB=EPODOC&CC=AU&NR=2012200575A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25543,76293</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20120223&DB=EPODOC&CC=AU&NR=2012200575A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>ASSEFA, HAREGEWEIN</creatorcontrib><creatorcontrib>BOWSER, TODD</creatorcontrib><creatorcontrib>BERNIAC, JOEL</creatorcontrib><creatorcontrib>NIHLAWI, MOHAMMED</creatorcontrib><creatorcontrib>MECHICHE, RACHID</creatorcontrib><creatorcontrib>OHEMENG, KWASI</creatorcontrib><creatorcontrib>KIM, OAK</creatorcontrib><creatorcontrib>BHATIA, BEENA</creatorcontrib><creatorcontrib>ABATO, PAUL</creatorcontrib><creatorcontrib>HONEYMAN, LAURA</creatorcontrib><creatorcontrib>GRIER, MARK</creatorcontrib><creatorcontrib>HOHOS, AARON</creatorcontrib><creatorcontrib>CHEN, JACKSON</creatorcontrib><creatorcontrib>SIZENSKY, EMMANUELLE</creatorcontrib><creatorcontrib>AMOO, VICTOR</creatorcontrib><creatorcontrib>NELSON, MARK L</creatorcontrib><creatorcontrib>MAIL, MOHAMED Y</creatorcontrib><title>Substituted tetracycline compounds</title><description>The present invention pertains, at least in part, to novel substituted tetracycline compounds. These tetracycline compounds can be used to treat numerous tetracycline 5 compound-responsive states, such as bacterial infections and neoplasms, as well as other known applications for tetracycline compounds such as blocking tetracycline efflux and modulation of gene expression.</description><subject>ACYCLIC OR CARBOCYCLIC COMPOUNDS</subject><subject>CHEMISTRY</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2012</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZFAKLk0qLsksKS1JTVEoSS0pSkyuTM7JzEtVSM7PLcgvzUsp5mFgTUvMKU7lhdLcDMpuriHOHrqpBfnxqcUFicmpeakl8Y6hRgaGRkYGBqbmpo6GxsSpAgCYfieI</recordid><startdate>20120223</startdate><enddate>20120223</enddate><creator>ASSEFA, HAREGEWEIN</creator><creator>BOWSER, TODD</creator><creator>BERNIAC, JOEL</creator><creator>NIHLAWI, MOHAMMED</creator><creator>MECHICHE, RACHID</creator><creator>OHEMENG, KWASI</creator><creator>KIM, OAK</creator><creator>BHATIA, BEENA</creator><creator>ABATO, PAUL</creator><creator>HONEYMAN, LAURA</creator><creator>GRIER, MARK</creator><creator>HOHOS, AARON</creator><creator>CHEN, JACKSON</creator><creator>SIZENSKY, EMMANUELLE</creator><creator>AMOO, VICTOR</creator><creator>NELSON, MARK L</creator><creator>MAIL, MOHAMED Y</creator><scope>EVB</scope></search><sort><creationdate>20120223</creationdate><title>Substituted tetracycline compounds</title><author>ASSEFA, HAREGEWEIN ; BOWSER, TODD ; BERNIAC, JOEL ; NIHLAWI, MOHAMMED ; MECHICHE, RACHID ; OHEMENG, KWASI ; KIM, OAK ; BHATIA, BEENA ; ABATO, PAUL ; HONEYMAN, LAURA ; GRIER, MARK ; HOHOS, AARON ; CHEN, JACKSON ; SIZENSKY, EMMANUELLE ; AMOO, VICTOR ; NELSON, MARK L ; MAIL, MOHAMED Y</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_AU2012200575A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2012</creationdate><topic>ACYCLIC OR CARBOCYCLIC COMPOUNDS</topic><topic>CHEMISTRY</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><toplevel>online_resources</toplevel><creatorcontrib>ASSEFA, HAREGEWEIN</creatorcontrib><creatorcontrib>BOWSER, TODD</creatorcontrib><creatorcontrib>BERNIAC, JOEL</creatorcontrib><creatorcontrib>NIHLAWI, MOHAMMED</creatorcontrib><creatorcontrib>MECHICHE, RACHID</creatorcontrib><creatorcontrib>OHEMENG, KWASI</creatorcontrib><creatorcontrib>KIM, OAK</creatorcontrib><creatorcontrib>BHATIA, BEENA</creatorcontrib><creatorcontrib>ABATO, PAUL</creatorcontrib><creatorcontrib>HONEYMAN, LAURA</creatorcontrib><creatorcontrib>GRIER, MARK</creatorcontrib><creatorcontrib>HOHOS, AARON</creatorcontrib><creatorcontrib>CHEN, JACKSON</creatorcontrib><creatorcontrib>SIZENSKY, EMMANUELLE</creatorcontrib><creatorcontrib>AMOO, VICTOR</creatorcontrib><creatorcontrib>NELSON, MARK L</creatorcontrib><creatorcontrib>MAIL, MOHAMED Y</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>ASSEFA, HAREGEWEIN</au><au>BOWSER, TODD</au><au>BERNIAC, JOEL</au><au>NIHLAWI, MOHAMMED</au><au>MECHICHE, RACHID</au><au>OHEMENG, KWASI</au><au>KIM, OAK</au><au>BHATIA, BEENA</au><au>ABATO, PAUL</au><au>HONEYMAN, LAURA</au><au>GRIER, MARK</au><au>HOHOS, AARON</au><au>CHEN, JACKSON</au><au>SIZENSKY, EMMANUELLE</au><au>AMOO, VICTOR</au><au>NELSON, MARK L</au><au>MAIL, MOHAMED Y</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Substituted tetracycline compounds</title><date>2012-02-23</date><risdate>2012</risdate><abstract>The present invention pertains, at least in part, to novel substituted tetracycline compounds. These tetracycline compounds can be used to treat numerous tetracycline 5 compound-responsive states, such as bacterial infections and neoplasms, as well as other known applications for tetracycline compounds such as blocking tetracycline efflux and modulation of gene expression.</abstract><oa>free_for_read</oa></addata></record> |
fulltext | fulltext_linktorsrc |
identifier | |
ispartof | |
issn | |
language | eng |
recordid | cdi_epo_espacenet_AU2012200575A1 |
source | esp@cenet |
subjects | ACYCLIC OR CARBOCYCLIC COMPOUNDS CHEMISTRY METALLURGY ORGANIC CHEMISTRY |
title | Substituted tetracycline compounds |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-24T20%3A35%3A48IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=ASSEFA,%20HAREGEWEIN&rft.date=2012-02-23&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EAU2012200575A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |